|
Orasure Technologies, Inc. (OSUR) Valoración de DCF
US | Healthcare | Medical - Instruments & Supplies | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
OraSure Technologies, Inc. (OSUR) Bundle
¡Descubra el verdadero potencial de Orasure Technologies, Inc. (OSUR) con nuestra calculadora DCF avanzada! Ajuste los supuestos clave, explore varios escenarios y evalúe cómo los cambios afectan la valoración de Orasure, todo dentro de una sola plantilla de Excel.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 154.6 | 171.7 | 233.7 | 387.5 | 405.5 | 524.7 | 679.0 | 878.6 | 1,136.9 | 1,471.2 |
| Revenue Growth, % | 0 | 11.07 | 36.08 | 65.82 | 4.64 | 29.4 | 29.4 | 29.4 | 29.4 | 29.4 |
| EBITDA | 15.5 | 3.4 | .0 | 10.3 | 64.4 | 32.1 | 41.5 | 53.7 | 69.5 | 90.0 |
| EBITDA, % | 10.04 | 2 | 0.00385152 | 2.66 | 15.87 | 6.12 | 6.12 | 6.12 | 6.12 | 6.12 |
| Depreciation | 7.3 | 9.4 | 11.7 | 14.0 | 20.9 | 25.2 | 32.6 | 42.1 | 54.5 | 70.6 |
| Depreciation, % | 4.75 | 5.47 | 4.99 | 3.61 | 5.16 | 4.8 | 4.8 | 4.8 | 4.8 | 4.8 |
| EBIT | 8.2 | -5.9 | -11.6 | -3.7 | 43.4 | 6.9 | 9.0 | 11.6 | 15.0 | 19.4 |
| EBIT, % | 5.3 | -3.46 | -4.99 | -0.9567 | 10.71 | 1.32 | 1.32 | 1.32 | 1.32 | 1.32 |
| Total Cash | 156.3 | 209.4 | 153.0 | 110.8 | 290.4 | 383.8 | 496.6 | 642.7 | 831.6 | 1,076.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 36.9 | 38.8 | 45.3 | 70.8 | 40.2 | 98.7 | 127.8 | 165.3 | 213.9 | 276.9 |
| Account Receivables, % | 23.9 | 22.62 | 19.4 | 18.27 | 9.91 | 18.82 | 18.82 | 18.82 | 18.82 | 18.82 |
| Inventories | 23.2 | 31.9 | 53.1 | 96.2 | 47.6 | 97.4 | 126.1 | 163.2 | 211.1 | 273.2 |
| Inventories, % | 14.98 | 18.56 | 22.74 | 24.84 | 11.74 | 18.57 | 18.57 | 18.57 | 18.57 | 18.57 |
| Accounts Payable | 9.6 | 17.4 | 28.0 | 38.0 | 13.2 | 43.4 | 56.2 | 72.7 | 94.1 | 121.7 |
| Accounts Payable, % | 6.19 | 10.14 | 11.99 | 9.81 | 3.24 | 8.27 | 8.27 | 8.27 | 8.27 | 8.27 |
| Capital Expenditure | -9.3 | -28.9 | -48.1 | -63.9 | -10.3 | -65.6 | -84.9 | -109.8 | -142.1 | -183.9 |
| Capital Expenditure, % | -6.02 | -16.84 | -20.59 | -16.49 | -2.54 | -12.5 | -12.5 | -12.5 | -12.5 | -12.5 |
| Tax Rate, % | 4.63 | 4.63 | 4.63 | 4.63 | 4.63 | 4.63 | 4.63 | 4.63 | 4.63 | 4.63 |
| EBITAT | 6.4 | -25.2 | -28.8 | -4.0 | 41.4 | 6.6 | 8.5 | 11.0 | 14.2 | 18.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -46.1 | -47.5 | -82.4 | -112.5 | 106.4 | -112.0 | -88.7 | -114.8 | -148.6 | -192.3 |
| WACC, % | 5.23 | 5.27 | 5.27 | 5.27 | 5.26 | 5.26 | 5.26 | 5.26 | 5.26 | 5.26 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -554.7 | |||||||||
| Long Term Growth Rate, % | 3.00 | |||||||||
| Free cash flow (T + 1) | -198 | |||||||||
| Terminal Value | -8,756 | |||||||||
| Present Terminal Value | -6,775 | |||||||||
| Enterprise Value | -7,330 | |||||||||
| Net Debt | -277 | |||||||||
| Equity Value | -7,053 | |||||||||
| Diluted Shares Outstanding, MM | 74 | |||||||||
| Equity Value Per Share | -94.82 |
What You Will Get
- Comprehensive OSUR Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Real-Time Calculations: Intrinsic value and NPV are computed automatically.
- Scenario Analysis: Evaluate various scenarios to assess OraSure’s future performance.
- User-Friendly Design: Designed for professionals while remaining accessible to newcomers.
Key Features
- Comprehensive OraSure Financials: Gain access to precise pre-loaded historical data and future forecasts for OraSure Technologies, Inc. (OSUR).
- Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- User-Friendly Dashboard: Intuitive charts and summaries to effectively visualize your valuation outcomes.
- Suitable for All Experience Levels: A straightforward, user-friendly design tailored for investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the prebuilt Excel template with OraSure Technologies, Inc.'s (OSUR) data included.
- Step 2: Explore the pre-filled sheets and familiarize yourself with the key metrics.
- Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view recalculated results, including OraSure Technologies, Inc.'s (OSUR) intrinsic value.
- Step 5: Make informed investment decisions or generate reports using the outputs.
Why Choose OraSure Technologies, Inc. (OSUR)?
- Innovative Solutions: Cutting-edge technology designed for effective health diagnostics.
- Proven Reliability: Trusted products that deliver consistent and accurate results.
- Comprehensive Support: Dedicated customer service to assist with any inquiries or needs.
- Industry Leader: Recognized for excellence in the diagnostic and healthcare sectors.
- Sustainable Practices: Commitment to environmentally friendly operations and products.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive and accurate valuation models for portfolio assessment.
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights for OraSure Technologies, Inc. (OSUR) to clients.
- Students and Educators: Utilize real-world data to practice and teach financial modeling techniques.
- Biotech Enthusiasts: Gain insights into how biotech companies like OraSure Technologies, Inc. (OSUR) are valued in the financial markets.
What the Template Contains
- Pre-Filled DCF Model: OraSure Technologies’ financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate OraSure Technologies’ profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.